Wall Street Analysts Predict a 36.47% Upside in Select Medical (SEM): Here's What You Should Know

Core Viewpoint - Select Medical (SEM) shares have increased by 7.8% in the past four weeks, closing at $13.19, with a mean price target of $18 indicating a potential upside of 36.5% [1] Price Targets and Analyst Estimates - The mean estimate consists of six short-term price targets with a standard deviation of $2.9, where the lowest estimate is $14.00 (6.1% increase) and the highest is $21.00 (59.2% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Sentiment - Analysts are optimistic about SEM's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has shown a strong correlation with stock price movements [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 1.1%, with one estimate moving higher and no negative revisions [12] Zacks Rank and Investment Potential - SEM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting the extent of gains, they can provide a directional guide for potential price movement [14]